9-99132728-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP2PP3_Strong
The NM_004612.4(TGFBR1):c.563G>T(p.Gly188Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004612.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR1 | NM_004612.4 | c.563G>T | p.Gly188Val | missense_variant | 3/9 | ENST00000374994.9 | NP_004603.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR1 | ENST00000374994.9 | c.563G>T | p.Gly188Val | missense_variant | 3/9 | 1 | NM_004612.4 | ENSP00000364133.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461834Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2024 | The p.G188V variant (also known as c.563G>T), located in coding exon 3 of the TGFBR1 gene, results from a G to T substitution at nucleotide position 563. The glycine at codon 188 is replaced by valine, an amino acid with dissimilar properties. This alteration alters the first amino acid of the highly conserved GS domain signature sequence (GSGSGLP) found in type I TGF beta receptors. This variant has been observed in at least three individuals with a personal and/or family history that is consistent with TGFBR1-related Loeys-Dietz syndrome and segregated with disease in at least one family (Ambry internal data; Ziganshin BA et al. Ann. Thorac. Surg. 2015;100:1604-11; Yamada S. Front Physiol. 2021 Aug;12:715687). Cells from aortic tissue of a heterozygous mouse model with this variant showed distorted and ruptured elastic fibers; however, the clinical relevance of this finding is unclear (Yamada S. Front Physiol. 2021 Aug;12:715687). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is likely pathogenic for TGFBR1-related Loeys-Dietz syndrome. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 12, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies show that this variant is embryonic lethality in homozygous state, and results in disorganized aortic elastic fibers and reduced lifespan in the heterozygous state, and causes disregulation of TGF-b signaling (Yamada et al., 2021).; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26188975, 34456753, 29543232) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at